US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist
  • 5.570
  • +0.090+1.64%
Trading Nov 21 11:59 ET
315.38MMarket Cap-6552P/E (TTM)

Design Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Design Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Design Therapeutics Earnings Reports

  • Design Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8 05:20

  • Design Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 5 20:17

  • Design Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 04:55

  • Design Therapeutics | 10-K: FY2023 Annual Report

    Mar 20 04:23

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data